Guardant Health, Inc, a leading precision oncology company, announced that its Shield blood test, recently approved by the U.S. Food and Drug Administration (FDA),...
Guardant Health, Inc., a leading precision oncology company, announced that Blue Cross and Blue Shield of Louisiana now offers coverage for the Guardant Reveal...
Guardant Health, Inc, a leading precision oncology company, announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX),...
Guardant Health, Inc., a leading precision oncology company, announced positive results from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode),...
